Stock events for Novanta, Inc. (NOVT)
Novanta's stock increased by 16.2% from January 1st, 2026, to May 9, 2026. The company reported Q4 2025 EPS of $0.91, beating estimates, but revenue slightly missed. Novanta announced its Q1 2026 earnings release schedule. Robert W. Baird upgraded Novanta's stock to "Outperform". Novanta joined the NVIDIA Halos AI Systems Inspection Lab. There was notable insider selling by the CEO and CFO. The stock was influenced by broader market trends, including AI sentiment and geopolitical tensions. Novanta acquired Keonn Technologies and strengthened its balance sheet through equity units and a new credit facility.
Demand Seasonality affecting Novanta, Inc.’s stock price
Novanta experiences some demand seasonality, with margins typically lower in the first quarter due to certain expenses. Its diversified portfolio, with a significant portion of sales from medical applications, provides resilience during fluctuating macroeconomic conditions.
Overview of Novanta, Inc.’s business
Novanta, Inc. is a global technology company specializing in precision components, subsystems, and software for photonics and motion control applications, serving OEMs in the medical device and advanced industrial markets. The company operates through three segments: Photonics, Vision (Medical Solutions), and Precision Motion, marketing its products under brands like Cambridge Technology and Celera Motion.
NOVT’s Geographic footprint
Novanta has an international presence with facilities in North America, Europe, and Asia, including design, engineering, and production centers in Germany, Italy, the United Kingdom, China, and Japan. In 2025, revenue distribution was 45% from North America, 30% from Europe, and 25% from Asia-Pacific.
NOVT Corporate Image Assessment
Novanta has a strong brand reputation as a trusted technology partner, recognized as a global leader in automation and medical solutions, and a premium innovator. The partnership with NVIDIA enhances its reputation in the advanced technology space.
Ownership
Novanta Inc.'s ownership is predominantly held by institutional investors, who collectively hold a substantial portion of the company's shares. Key institutional holders include BlackRock, Inc., Vanguard Group Inc, Conestoga Capital Advisors, LLC, Allspring Global Investments Holdings, LLC, and State Street Corp. Insider ownership is relatively small, at approximately 0.82% to 1.5%. Public companies and individual investors account for the remaining shares, roughly 10.66% to 29.16%.
Ask Our Expert AI Analyst
Price Chart
$159.33